Detalhe da pesquisa
1.
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.
Breast Cancer Res Treat
; 195(3): 341-351, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986801
2.
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.
Clin Cancer Res
; 24(23): 5939-5947, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30068706